BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37992218)

  • 1. Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation.
    Böhm S; Wustrau K; Pachlopnik Schmid J; Prader S; Ahlmann M; Yacobovich J; Beier R; Speckmann C; Behnisch W; Ifversen M; Jordan M; Marsh R; Naumann-Bartsch N; Mauz-Körholz C; Hönig M; Schulz A; Malinowska I; Hines M; Nichols KE; Gil-Herrera J; Talano JA; Crooks B; Formankova R; Jorch N; Bakhtiar S; Kühnle I; Streiter M; Nathrath M; Russo A; Dürken M; Lang P; Lindemans C; Henter JI; Lehmberg K; Ehl S
    Blood; 2024 Mar; 143(10):872-881. PubMed ID: 37992218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.
    Bergsten E; Horne A; Aricó M; Astigarraga I; Egeler RM; Filipovich AH; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Montgomery S; Nanduri V; Rosso D; Henter JI
    Blood; 2017 Dec; 130(25):2728-2738. PubMed ID: 28935695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
    Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
    Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis.
    Ge J; Zhang Q; Ma H; Wang D; Zhao Y; Zhu T; Wang W; Zhou C; Wei A; Lian H; Qin M; Yang J; Li Z; Wang T; Zhang R
    Haematologica; 2024 Feb; 109(2):458-465. PubMed ID: 37470145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL).
    Merli P; Algeri M; Gaspari S; Locatelli F
    Front Immunol; 2020; 11():608492. PubMed ID: 33424859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical characteristics of adult hemophagocytic lymphohistiocytosis treated with haploidentical donor hematopoietic stem cell transplantation].
    Fu L; Wei N; Wang JS; Wu L; Wang YN; Huang DY; Liu JL; Wang Z
    Zhonghua Nei Ke Za Zhi; 2017 Apr; 56(4):273-278. PubMed ID: 28355720
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children.
    Zhao C; Zhang Q; Zhang R; Lian H; Ma H; Zhao X; Li Z
    Ann Hematol; 2024 Jan; 103(1):17-28. PubMed ID: 37851074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of haploidentical hematopoietic stem cell transplantation on 15 cases of adult-onset primary hemophagocytic lymphohistiocytosis].
    Wang YN; Wang JS; Wei N; Wu L; Jin ZL; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):511-516. PubMed ID: 32654467
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
    Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
    Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of allogeneic hematopoietic stem cell transplantation for primary hemophagocytic lymphohistiocytosis in adults.
    He L; Wang Y; Suolitiken D; Zhang R; Liu M; Hua Z; Yao S; Zou H; Wang Z
    Hematol Oncol; 2022 Aug; 40(3):390-399. PubMed ID: 35526261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.
    Ehl S; Astigarraga I; von Bahr Greenwood T; Hines M; Horne A; Ishii E; Janka G; Jordan MB; La Rosée P; Lehmberg K; Machowicz R; Nichols KE; Sieni E; Wang Z; Henter JI
    J Allergy Clin Immunol Pract; 2018; 6(5):1508-1517. PubMed ID: 30201097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Ali S; AlThubaiti S; Renzi S; Krueger J; Chiang KY; Naqvi A; Schechter T; Punnett A; Ali M
    Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis.
    Garonzi C; Chinello M; Cesaro S
    Expert Rev Clin Pharmacol; 2021 May; 14(5):527-534. PubMed ID: 33686916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
    Chandrakasan S; Jordan MB; Baker A; Behrens EM; Bhatla D; Chien M; Eckstein OS; Henry MM; Hermiston ML; Hinson AP; Leiding JW; Oladapo A; Patel SA; Pednekar P; Ray AK; Dávila Saldaña B; Sarangi SN; Walkovich KJ; Yee JD; Zoref-Lorenz A; Allen CE
    Blood Adv; 2024 May; 8(9):2248-2258. PubMed ID: 38429096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of Current and Emerging Therapeutic Options for Hemophagocytic Lymphohistiocytosis.
    Summerlin J; Wells DA; Anderson MK; Halford Z
    Ann Pharmacother; 2023 Jul; 57(7):867-879. PubMed ID: 36349896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
    Segal JE; Daley JD; Barnum JL; Salgado CM; Reyes-Mugica M; Schneider C; Gumus S; Thakrar D; Allen SW; Canna SW
    J Clin Immunol; 2021 Jul; 41(5):987-991. PubMed ID: 33570715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis.
    Yoon HS; Im HJ; Moon HN; Lee JH; Kim HJ; Yoo KH; Sung KW; Koo HH; Kang HJ; Shin HY; Ahn HS; Cho B; Kim HK; Lyu CJ; Lee MJ; Kook H; Hwang TJ; Seo JJ
    Pediatr Transplant; 2010 Sep; 14(6):735-40. PubMed ID: 20113424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study.
    Bergsten E; Horne A; Hed Myrberg I; Aricó M; Astigarraga I; Ishii E; Janka G; Ladisch S; Lehmberg K; McClain KL; Minkov M; Nanduri V; Rosso DA; Sieni E; Winiarski J; Henter JI
    Blood Adv; 2020 Aug; 4(15):3754-3766. PubMed ID: 32780845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
    Ono S; Okano T; Hoshino A; Yanagimachi M; Hamamoto K; Nakazawa Y; Imamura T; Onuma M; Niizuma H; Sasahara Y; Tsujimoto H; Wada T; Kunisaki R; Takagi M; Imai K; Morio T; Kanegane H
    J Clin Immunol; 2017 Jan; 37(1):85-91. PubMed ID: 27815752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.